Coriolus versicolor and its bioactive molecule are potential immunomodulators against cancer cell metastasis via inactivation of MAPK pathway

Copyright © 2022. Published by Elsevier B.V..

ETHNOPHARMACOLOGICAL RELEVANCE: Coriolus versicolor (CV) has been used in traditional Chinese medicine for over 2000 years as a premium medicine for enhancing good health and longevity. The immunomodulatory and anti-cancer effects of polysaccharopeptides (PSP) from cultured CV have been extensively studied; however, the effect and the mechanism of action of other small molecules from CV remain unknown.

AIM OF THE STUDY: we aim to examine the immunomodulatory and anti-cancer effects of the small molecules from CV (SMCV) and identify the active compounds that are responsible for the biological effects against glioblastoma multiforme cells.

MATERIALS AND METHODS: The effects of SMCV/active compound on cytokine and MMP mRNA expressions and productions were assessed by quantitative reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. An active compound from SMCV was identified with a bioassay-guided fractionation scheme. The potential mode of action of the active compound was further investigated by identifying the cell signaling pathway. The protein expressions of phospho-ERK, phospho-JNK and phospho-p38 MAPKs were measured by Western Blotting. The anti-invasive effect of SMCV/bioactive compound against T98G, lung carcinoma (A549), and breast adenocarcinoma (MDA-MB-231) cells were determined using invasion assay.

RESULTS: Our results showed that SMCV had strong immunomodulatory effect by suppressing LPS-induced TNF-α production, whereas increasing poly I:C-induced IFN-β level in PBMac. SMCV not only possessed indirect anti-cancer effect by suppressing TNF-α-induced MMP-3 production in glioblastoma T98G cells, but also directly reduced the invasion ability of malignant cells including T98G, A549 and MDA-MB-231. Using bioassay-guided fractionation scheme, we isolated 9-KODE methyl ester (compound AM) that was responsible for the bioactivity of SMCV. This compound suppressed TNF-α-induced MMP-3 production in T98G cells and the suppression may be correlated with the inactivation of p38 mitogen-activated protein kinase (MAPK) pathway. Moreover, compound AM also directly reduced T98G cell invasion.

CONCLUSION: Results of our present study provides scientific evidence that SMCV possesses immunomodulatory and anti-cancer effects. Its bioactive compound, compound AM, is a potential new drug candidate against the invasion and metastasis of glioblastoma cells.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:301

Enthalten in:

Journal of ethnopharmacology - 301(2023) vom: 30. Jan., Seite 115790

Sprache:

Englisch

Beteiligte Personen:

Yang, Cindy Lai-Hung [VerfasserIn]
Chik, Stanley Chi-Chung [VerfasserIn]
Lau, Allan Sik-Yin [VerfasserIn]
Chan, Godfrey Chi-Fung [VerfasserIn]

Links:

Volltext

Themen:

9-KODE methyl Ester
Anti-Invasion
Coriolus versicolor
EC 2.7.11.24
EC 3.4.24.17
Glioblastoma
Immunologic Factors
Immunomodulatory
Journal Article
Matrix Metalloproteinase 3
Mitogen-Activated Protein Kinases
P38 Mitogen-Activated Protein Kinases
Tumor Necrosis Factor-alpha

Anmerkungen:

Date Completed 09.11.2022

Date Revised 09.11.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.jep.2022.115790

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM347240976